Decoy Therapeutics (DCOY) Proxy filing summary

Executive summary

• Annual Meeting scheduled for July 14, 2026, at 10:00 a.m. CT, to be held virtually with online registration required.

• Proxy materials, including the Proxy Statement and Annual Report, are available online, with options to request paper or email copies.

• Shareholders are encouraged to review all proxy materials before voting and can vote online, by phone, or during the virtual meeting.

Voting matters and shareholder proposals

• Election of three directors: Patricia Gauthier, Jonathan Lieber, and Frederick E. Pierce, with board recommendation to vote FOR all nominees.

• Advisory vote to approve executive compensation on a non-binding basis, recommended FOR by the board.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026, recommended FOR by the board.

• Provision for other business to be conducted as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends voting FOR all director nominees and proposals presented.

• Virtual meeting format requires shareholders to register and use a control number to participate and vote.